Incidence, Therapy, and Bleeding Risk—Cancer- Associated Thrombosis in Patients with Glioblastoma
Cancer is an independent risk factor for the development of venous thromboembolism (VTE). Glioblastomas are amongst cancer types with the most thrombogenic potential and patients are at a particularly high risk of VTE with an incidence up to 20–30% per year. Currently, major efforts are underway to...
Main Authors: | Viktoria Muster, Thomas Gary |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1354 |
Similar Items
-
Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
by: Viktoria Muster, et al.
Published: (2021-06-01) -
A review on superficial venous thrombosis of the lower extremities
by: Yung-Wei Chi, et al.
Published: (2019-01-01) -
The Role of Direct Oral Anticoagulants in Cancer-Associated Thrombosis According to the Current Literature
by: Petroula Nana, et al.
Published: (2021-09-01) -
Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
by: Sven R. Olson, et al.
Published: (2019-07-01) -
Fondaparinux
by: G. Airoldi, et al.
Published: (2013-05-01)